Pioneering collaboration advances nuclear medicine
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
Showing 1 - 20 of 62 results
This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.
ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.
Bushfires in proximity to ANSTO during the 2018 bushfires.
Australia’s new state-of-the-art nuclear medicine facility gets green light.
See details of previously published customer updates from our Health products team.
indigenous Cultural Intellectual Property is a broader way of talking about First Peoples’ rights to their cultural heritage, traditional knowledge and cultural expressions.
ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.
ANSTO offers a broad range of programs and services to various industries and customers. Many of these services, including the Australian Nuclear Medicine Traceability program, are supported by online customer portals.
Radioisotopes are widely used in medicine, industry, and scientific research. New applications for radioisotopes are constantly being developed.